Daniel Krug (Rolf Müller)

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 142

Top Venues

ACS chemical biology

Journal of the American Chemical Society

Nature communications

EMBO reports

Helmholtz Institute for Pharmaceutical Research Saarland

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Helmholtz Institute for Pharmaceutical Research Saarland Aug 01 2009

Germany

Head of Department :: Microbial Natural Products

Publications

Christine Beemelmanns, Andreas Keller, Daniel Krug
Mining the microbiota for antibiotics. Nature microbiology (2024)
Sebastian Adam, Franziska Fries, Alexander von Tesmar, Sari Rasheed, Selina Deckarm, Carla F Sousa, Roman Reberšek, Timo Risch, Stefano Mancini, Jennifer Herrmann, Jesko Koehnke, Olga V Kalinina, Daniel Krug
The Peptide Antibiotic Corramycin Adopts a β-Hairpin-like Structure and Is Inactivated by the Kinase ComG. Journal of the American Chemical Society 146 (13) (2024)
Sebastian Adam, Franziska Fries, Alexander von Tesmar, Sari Rasheed, Selina Deckarm, Carla F Sousa, Roman Reberšek, Timo Risch, Stefano Mancini, Jennifer Herrmann, Jesko Koehnke, Olga V Kalinina, Daniel Krug
The Peptide Antibiotic Corramycin Adopts a β-Hairpin-like Structure and Is Inactivated by the Kinase ComG. Journal of the American Chemical Society 146 (13) (2024)
Sebastian Walesch, Ronald Garcia, Abdelhalim B Mahmoud, Fabian Panter, Sophie Bollenbach, Pascal Mäser, Marcel Kaiser, Daniel Krug
New myxobacteria of the Myxococcaceae clade produce angiolams with antiparasitic activities. Microbiology spectrum 12 (3) (2024)
Danny Solga, Lianne H E Wieske, Scott Wilcox, Carsten Zeilinger, Linda Jansen-Olliges, Katarina Cirnski, Jennifer Herrmann, Daniel Krug, Máté Erdélyi, Andreas Kirschning
Is Simultaneous Binding to DNA and Gyrase Important for the Antibacterial Activity of Cystobactamids? Chemistry (Weinheim an der Bergstrasse, Germany) 30 (19) (2024)
Lisa Osbelt, Éva D H Almási, Marie Wende, Sabine Kienesberger, Alexander Voltz, Till R Lesker, Uthayakumar Muthukumarasamy, Nele Knischewski, Elke Nordmann, Agata A Bielecka, María Giralt-Zúñiga, Eugen Kaganovitch, Caroline Kühne, Claas Baier, Michael Pietsch, Mathias Müsken, Marina C Greweling-Pils, Rolf Breinbauer, Antje Flieger, Dirk Schlüter, Daniel Krug, Marc Erhardt, Ellen L Zechner, Till Strowig
Klebsiella oxytoca inhibits Salmonella infection through multiple microbiota-context-dependent mechanisms. Nature microbiology 9 (7) (2024)
Sebastian Adam, Franziska Fries, Alexander von Tesmar, Sari Rasheed, Selina Deckarm, Carla F Sousa, Roman Reberšek, Timo Risch, Stefano Mancini, Jennifer Herrmann, Jesko Koehnke, Olga V Kalinina, Daniel Krug
The Peptide Antibiotic Corramycin Adopts a β-Hairpin-like Structure and Is Inactivated by the Kinase ComG. Journal of the American Chemical Society 146 (13) (2024)
Danny Solga, Lianne H E Wieske, Scott Wilcox, Carsten Zeilinger, Linda Jansen-Olliges, Katarina Cirnski, Jennifer Herrmann, Daniel Krug, Máté Erdélyi, Andreas Kirschning
Is Simultaneous Binding to DNA and Gyrase Important for the Antibacterial Activity of Cystobactamids? Chemistry (Weinheim an der Bergstrasse, Germany) (2024)
Walter Hofer, Felix Deschner, Gwenaëlle Jézéquel, Laìs Pessanha de Carvalho, Noran Abdel-Wadood, Linda Pätzold, Steffen Bernecker, Bernd Morgenstern, Andreas Martin Kany, Miriam Große, Marc Stadler, Markus Bischoff, Anna Katharina Herta Hirsch, Jana Held, Jennifer Herrmann, Daniel Krug
Functionalization of Chlorotonils: Dehalogenil as Promising Lead Compound for In Vivo Application. Angewandte Chemie (International ed. in English) 63 (19) (2024)
Sebastian Walesch, Ronald Garcia, Abdelhalim B Mahmoud, Fabian Panter, Sophie Bollenbach, Pascal Mäser, Marcel Kaiser, Daniel Krug
New myxobacteria of the Myxococcaceae clade produce angiolams with antiparasitic activities. Microbiology spectrum 12 (3) (2024)
Christine Beemelmanns, Andreas Keller, Daniel Krug
Mining the microbiota for antibiotics. Nature microbiology 9 (1) (2024)
Danny Solga, Lianne H E Wieske, Scott Wilcox, Carsten Zeilinger, Linda Jansen-Olliges, Katarina Cirnski, Jennifer Herrmann, Daniel Krug, Máté Erdélyi, Andreas Kirschning
Is Simultaneous Binding to DNA and Gyrase Important for the Antibacterial Activity of Cystobactamids? Chemistry (Weinheim an der Bergstrasse, Germany) 30 (19) (2024)
Lisa Osbelt, Éva D H Almási, Marie Wende, Sabine Kienesberger, Alexander Voltz, Till R Lesker, Uthayakumar Muthukumarasamy, Nele Knischewski, Elke Nordmann, Agata A Bielecka, María Giralt-Zúñiga, Eugen Kaganovitch, Caroline Kühne, Claas Baier, Michael Pietsch, Mathias Müsken, Marina C Greweling-Pils, Rolf Breinbauer, Antje Flieger, Dirk Schlüter, Daniel Krug, Marc Erhardt, Ellen L Zechner, Till Strowig
Klebsiella oxytoca inhibits Salmonella infection through multiple microbiota-context-dependent mechanisms. Nature microbiology 9 (7) (2024)
Lisa Osbelt, Éva D H Almási, Marie Wende, Sabine Kienesberger, Alexander Voltz, Till R Lesker, Uthayakumar Muthukumarasamy, Nele Knischewski, Elke Nordmann, Agata A Bielecka, María Giralt-Zúñiga, Eugen Kaganovitch, Caroline Kühne, Claas Baier, Michael Pietsch, Mathias Müsken, Marina C Greweling-Pils, Rolf Breinbauer, Antje Flieger, Dirk Schlüter, Daniel Krug, Marc Erhardt, Ellen L Zechner, Till Strowig
Klebsiella oxytoca inhibits Salmonella infection through multiple microbiota-context-dependent mechanisms. Nature microbiology 9 (7) (2024)
Daniel Kohnhäuser, Tim Seedorf, Katarina Cirnski, Dominik Heimann, Janetta Coetzee, Sylvie Sordello, Jana Richter, Moritz Stappert, Jean-Francois Sabuco, David Corbett, Eric Bacqué, Katharina Rox, Jennifer Herrmann, Aurelie Vassort, Daniel Krug, Andreas Kirschning, Mark Brönstrup
Optimization of the Central α-Amino Acid in Cystobactamids to the Broad-Spectrum, Resistance-Breaking Antibiotic CN-CC-861. Journal of medicinal chemistry (2024)
Chengzhang Fu, Yunkun Liu, Christine Walt, Sari Rasheed, Chantal D Bader, Peer Lukat, Markus Neuber, F P Jake Haeckl, Wulf Blankenfeldt, Olga V Kalinina, Daniel Krug
Elucidation of unusual biosynthesis and DnaN-targeting mode of action of potent anti-tuberculosis antibiotics Mycoplanecins. Nature communications 15 (1) (2024)
Chengzhang Fu, Yunkun Liu, Christine Walt, Sari Rasheed, Chantal D Bader, Peer Lukat, Markus Neuber, F P Jake Haeckl, Wulf Blankenfeldt, Olga V Kalinina, Daniel Krug
Elucidation of unusual biosynthesis and DnaN-targeting mode of action of potent anti-tuberculosis antibiotics Mycoplanecins. Nature communications 15 (1) (2024)
Franziska Fries, Andreas Martin Kany, Sari Rasheed, Anna Katharina Herta Hirsch, Daniel Krug, Jennifer Herrmann
Correction: Fries et al. Impact of Drug Administration Routes on the In Vivo Efficacy of the Natural Product Sorangicin A Using a Staphylococcus aureus Infection Model in Zebrafish Embryos. Int. J. Mol. Sci. 2023, 24 , 12791. International journal of molecular sciences 25 (4) (2024)
Lisa Osbelt, Éva D H Almási, Marie Wende, Sabine Kienesberger, Alexander Voltz, Till R Lesker, Uthayakumar Muthukumarasamy, Nele Knischewski, Elke Nordmann, Agata A Bielecka, María Giralt-Zúñiga, Eugen Kaganovitch, Caroline Kühne, Claas Baier, Michael Pietsch, Mathias Müsken, Marina C Greweling-Pils, Rolf Breinbauer, Antje Flieger, Dirk Schlüter, Daniel Krug, Marc Erhardt, Ellen L Zechner, Till Strowig
Klebsiella oxytoca inhibits Salmonella infection through multiple microbiota-context-dependent mechanisms. Nature microbiology 9 (7) (2024)
Sebastian Walesch, Ronald Garcia, Abdelhalim B Mahmoud, Fabian Panter, Sophie Bollenbach, Pascal Mäser, Marcel Kaiser, Daniel Krug
New myxobacteria of the Myxococcaceae clade produce angiolams with antiparasitic activities. Microbiology spectrum (2024)
Lisa Osbelt, Éva D H Almási, Marie Wende, Sabine Kienesberger, Alexander Voltz, Till R Lesker, Uthayakumar Muthukumarasamy, Nele Knischewski, Elke Nordmann, Agata A Bielecka, María Giralt-Zúñiga, Eugen Kaganovitch, Caroline Kühne, Claas Baier, Michael Pietsch, Mathias Müsken, Marina C Greweling-Pils, Rolf Breinbauer, Antje Flieger, Dirk Schlüter, Daniel Krug, Marc Erhardt, Ellen L Zechner, Till Strowig
Klebsiella oxytoca inhibits Salmonella infection through multiple microbiota-context-dependent mechanisms. Nature microbiology (2024)
Katharina Rox, Annett Kühne, Jennifer Herrmann, Rolf Jansen, Stephan Hüttel, Steffen Bernecker, Yohannes Hagos, Mark Brönstrup, Marc Stadler, Thomas Hesterkamp, Daniel Krug
Interaction of the Atypical Tetracyclines Chelocardin and Amidochelocardin with Renal Drug Transporters. ACS pharmacology & translational science 7 (7) (2024)
Christine Beemelmanns, Andreas Keller, Daniel Krug
Mining the microbiota for antibiotics. Nature microbiology 9 (1) (2024)
Sebastian Adam, Franziska Fries, Alexander von Tesmar, Sari Rasheed, Selina Deckarm, Carla F Sousa, Roman Reberšek, Timo Risch, Stefano Mancini, Jennifer Herrmann, Jesko Koehnke, Olga V Kalinina, Daniel Krug
The Peptide Antibiotic Corramycin Adopts a β-Hairpin-like Structure and Is Inactivated by the Kinase ComG. Journal of the American Chemical Society (2024)
Chengzhang Fu, Yunkun Liu, Christine Walt, Sari Rasheed, Chantal D Bader, Peer Lukat, Markus Neuber, F P Jake Haeckl, Wulf Blankenfeldt, Olga V Kalinina, Daniel Krug
Elucidation of unusual biosynthesis and DnaN-targeting mode of action of potent anti-tuberculosis antibiotics Mycoplanecins. Nature communications 15 (1) (2024)
Walter Hofer, Felix Deschner, Gwenaëlle Jézéquel, Laìs Pessanha de Carvalho, Noran Abdel-Wadood, Linda Pätzold, Steffen Bernecker, Bernd Morgenstern, Andreas Martin Kany, Miriam Große, Marc Stadler, Markus Bischoff, Anna Katharina Herta Hirsch, Jana Held, Jennifer Herrmann, Daniel Krug
Functionalization of Chlorotonils: Dehalogenil as Promising Lead Compound for In Vivo Application. Angewandte Chemie (International ed. in English) (2024)
Katharina Rox, Annett Kühne, Jennifer Herrmann, Rolf Jansen, Stephan Hüttel, Steffen Bernecker, Yohannes Hagos, Mark Brönstrup, Marc Stadler, Thomas Hesterkamp, Daniel Krug
Interaction of the Atypical Tetracyclines Chelocardin and Amidochelocardin with Renal Drug Transporters. ACS pharmacology & translational science 7 (7) (2024)
Sebastian Walesch, Ronald Garcia, Abdelhalim B Mahmoud, Fabian Panter, Sophie Bollenbach, Pascal Mäser, Marcel Kaiser, Daniel Krug
New myxobacteria of the Myxococcaceae clade produce angiolams with antiparasitic activities. Microbiology spectrum 12 (3) (2024)
Sebastian Adam, Franziska Fries, Alexander von Tesmar, Sari Rasheed, Selina Deckarm, Carla F Sousa, Roman Reberšek, Timo Risch, Stefano Mancini, Jennifer Herrmann, Jesko Koehnke, Olga V Kalinina, Daniel Krug
The Peptide Antibiotic Corramycin Adopts a β-Hairpin-like Structure and Is Inactivated by the Kinase ComG. Journal of the American Chemical Society 146 (13) (2024)
Franziska Fries, Andreas Martin Kany, Sari Rasheed, Anna Katharina Herta Hirsch, Daniel Krug, Jennifer Herrmann
Correction: Fries et al. Impact of Drug Administration Routes on the In Vivo Efficacy of the Natural Product Sorangicin A Using a Staphylococcus aureus Infection Model in Zebrafish Embryos. Int. J. Mol. Sci. 2023, 24 , 12791. International journal of molecular sciences 25 (4) (2024)
Walter Hofer, Felix Deschner, Gwenaëlle Jézéquel, Laìs Pessanha de Carvalho, Noran Abdel-Wadood, Linda Pätzold, Steffen Bernecker, Bernd Morgenstern, Andreas Martin Kany, Miriam Große, Marc Stadler, Markus Bischoff, Anna Katharina Herta Hirsch, Jana Held, Jennifer Herrmann, Daniel Krug
Functionalization of Chlorotonils: Dehalogenil as Promising Lead Compound for In Vivo Application. Angewandte Chemie (International ed. in English) 63 (19) (2024)
Pascal Hirsch, Azat M Tagirdzhanov, Aleksandra Kushnareva, Ilia Olkhovskii, Simon Graf, Georges P Schmartz, Julian D Hegemann, Kenan A J Bozhüyük, Daniel Krug, Andreas Keller, Alexey Gurevich
ABC-HuMi: the Atlas of Biosynthetic Gene Clusters in the Human Microbiome. Nucleic acids research (2023)
Yu Mi Park, Markus R Meyer, Daniel Krug, Jennifer Herrmann
Optimization of Mass Spectrometry Imaging for Drug Metabolism and Distribution Studies in the Zebrafish Larvae Model: A Case Study with the Opioid Antagonist Naloxone. International journal of molecular sciences 24 (12) (2023)
Timm O Koller, Ullrich Scheid, Teresa Kösel, Jennifer Herrmann, Daniel Krug, Helena I M Boshoff, Bertrand Beckert, Joanna C Evans, Jan Schlemmer, Becky Sloan, Danielle M Weiner, Laura E Via, Atica Moosa, Thomas R Ioerger, Michael Graf, Boris Zinshteyn, Maha Abdelshahid, Fabian Nguyen, Stefan Arenz, Franziska Gille, Maik Siebke, Tim Seedorf, Oliver Plettenburg, Rachel Green, Anna-Luisa Warnke, Joachim Ullrich, Ralf Warrass, Clifton E Barry, Digby Francis Warner, Valerie Mizrahi, Andreas Kirschning, Daniel N Wilson, Daniel Krug
The Myxobacterial Antibiotic Myxovalargin: Biosynthesis, Structural Revision, Total Synthesis, and Molecular Characterization of Ribosomal Inhibition. Journal of the American Chemical Society (2023)
Sophia Gessner, Zela Alexandria-Mae Martin, Michael Anton Reiche, Joana A Santos, Ryan Dinkele, Atondaho Ramudzuli, Neeraj Dhar, Timothy J de Wet, Saber Anoosheh, Dirk M Lang, Jesse Arron, Teng Leong Chew, Jennifer Herrmann, Daniel Krug, John D Mckinney, Roger Woodgate, Valerie Mizrahi, Česlovas Venclovas, Meindert Hugo Lamers, Digby Francis Warner
The mycobacterial ImuA'-ImuB-DnaE2 mutasome: composition and recruitment in live cells. eLife 12 (2023)
Katharina Rox, Rolf Jansen, Tadeja Lukežič, Marina Greweling-Pils, Jennifer Herrmann, Marcus Miethke, Stephan Hüttel, Fabienne Hennessen, Antoine Abou Fayad, Cornelia Holzhausen, Carina Vingsbo Lundberg, Joanne Teague, Enge Sudarman, Lisa Bülter, Thomas Hesterkamp, Marc Stadler, Mark Brönstrup, Daniel Krug
Pharmacokinetic and pharmacodynamic evaluation of the atypical tetracyclines chelocardin and amidochelocardin in murine infection models. Microbiology spectrum (2023)
Yu Mi Park, Markus R Meyer, Daniel Krug, Jennifer Herrmann
Optimization of Mass Spectrometry Imaging for Drug Metabolism and Distribution Studies in the Zebrafish Larvae Model: A Case Study with the Opioid Antagonist Naloxone. International journal of molecular sciences 24 (12) (2023)
Sergi H Akone, Joachim J Hug, Amninder Kaur, Ronald Garcia, Daniel Krug
Structure Elucidation and Biosynthesis of Nannosterols A and B, Myxobacterial Sterols from Nannocystis sp. MNa10993. Journal of natural products (2023)
Zong-Jie Wang, Xiaotong Liu, Haibo Zhou, Yang Liu, Qiang Tu, Liujie Huo, Fu Yan, Daniel Krug, Youming Zhang, Xiaokun Xu
Engineered Biosynthesis of Complex Disorazol Polyketides in a Streamlined Burkholderia thailandensis . ACS synthetic biology (2023)
Felix Deschner, Timo Risch, Claas Baier, Dirk Schlüter, Jennifer Herrmann, Daniel Krug
Nitroxoline resistance is associated with significant fitness loss and diminishes in vivo virulence of Escherichia coli . Microbiology spectrum (2023)
Simon Graspeuntner, Katharina Koethke, Celeste Scholz, Lea Semmler, Mariia Lupatsii, Laura Kirchhoff, Jennifer Herrmann, Katharina Rox, Kathrin Wittstein, Nadja Käding, Lars C Hanker, Marc Stadler, Mark Brönstrup, Daniel Krug, Kensuke Shima, Jan Rupp
Sorangicin A Is Active against Chlamydia in Cell Culture, Explanted Fallopian Tubes, and Topical In Vivo Treatment. Antibiotics (Basel, Switzerland) 12 (5) (2023)
Timm O Koller, Ullrich Scheid, Teresa Kösel, Jennifer Herrmann, Daniel Krug, Helena I M Boshoff, Bertrand Beckert, Joanna C Evans, Jan Schlemmer, Becky Sloan, Danielle M Weiner, Laura E Via, Atica Moosa, Thomas R Ioerger, Michael Graf, Boris Zinshteyn, Maha Abdelshahid, Fabian Nguyen, Stefan Arenz, Franziska Gille, Maik Siebke, Tim Seedorf, Oliver Plettenburg, Rachel Green, Anna-Luisa Warnke, Joachim Ullrich, Ralf Warrass, Clifton E Barry, Digby Francis Warner, Valerie Mizrahi, Andreas Kirschning, Daniel N Wilson, Daniel Krug
The Myxobacterial Antibiotic Myxovalargin: Biosynthesis, Structural Revision, Total Synthesis, and Molecular Characterization of Ribosomal Inhibition. Journal of the American Chemical Society 145 (2) (2023)
Yunsheng Gao, Joy Birkelbach, Chengzhang Fu, Jennifer Herrmann, Herbert Irschik, Bernd Morgenstern, Kerstin Hirschfelder, Ruijuan Li, Youming Zhang, Rolf Jansen, Daniel Krug
The Disorazole Z Family of Highly Potent Anticancer Natural Products from Sorangium cellulosum: Structure, Bioactivity, Biosynthesis, and Heterologous Expression. Microbiology spectrum (2023)
Yu Mi Park, Markus R Meyer, Daniel Krug, Jennifer Herrmann
Optimization of Mass Spectrometry Imaging for Drug Metabolism and Distribution Studies in the Zebrafish Larvae Model: A Case Study with the Opioid Antagonist Naloxone. International journal of molecular sciences 24 (12) (2023)
Sebastian Adam, Dazhong Zheng, Andreas Klein, Carsten Volz, William Mullen, Sally L Shirran, Brian O Smith, Olga V Kalinina, Daniel Krug, Jesko Koehnke
Unusual peptide-binding proteins guide pyrroloindoline alkaloid formation in crocagin biosynthesis. Nature chemistry (2023)
Timm O Koller, Ullrich Scheid, Teresa Kösel, Jennifer Herrmann, Daniel Krug, Helena I M Boshoff, Bertrand Beckert, Joanna C Evans, Jan Schlemmer, Becky Sloan, Danielle M Weiner, Laura E Via, Atica Moosa, Thomas R Ioerger, Michael Graf, Boris Zinshteyn, Maha Abdelshahid, Fabian Nguyen, Stefan Arenz, Franziska Gille, Maik Siebke, Tim Seedorf, Oliver Plettenburg, Rachel Green, Anna-Luisa Warnke, Joachim Ullrich, Ralf Warrass, Clifton E Barry, Digby Francis Warner, Valerie Mizrahi, Andreas Kirschning, Daniel N Wilson, Daniel Krug
The Myxobacterial Antibiotic Myxovalargin: Biosynthesis, Structural Revision, Total Synthesis, and Molecular Characterization of Ribosomal Inhibition. Journal of the American Chemical Society 145 (2) (2023)
Michael W Mullowney, Katherine R Duncan, Somayah S Elsayed, Neha Garg, Justin Johan Jozias van der Hooft, Nathaniel I Martin, David Meijer, Barbara R Terlouw, Friederike Biermann, Kai Blin, Janani Durairaj, Marina Gorostiola González, Eric J N Helfrich, Florian Huber, Stefan Leopold-Messer, Kohulan Rajan, Tristan de Rond, Jeffrey A van Santen, Maria Sorokina, Marcy J Balunas, Mehdi A Beniddir, Doris A van Bergeijk, Laura M Carroll, Chase M Clark, Djork-Arné Clevert, Chris A Dejong, Chao Du, Scarlet Ferrinho, Francesca Grisoni, Albert Hofstetter, Willem Jespers, Olga V Kalinina, Satria A Kautsar, Hyun Woo Kim, Tiago F Leao, Joleen Masschelein, Evan R Rees, Raphael Reher, Daniel Reker, Philippe Schwaller, Marwin Segler, Michael A Skinnider, Allison S Walker, Egon L Wilighagen, Barbara Zdrazil, Nadine Ziemert, Rebecca J M Goss, Pierre Guyomard, Andrea Volkamer, William H Gerwick, Hyun Uk Kim, Daniel Krug, Gilles P van Wezel, Gerard van Westen, Anna Katharina Herta Hirsch, Roger G Linington, Serina L Robinson, Marnix H Medema
Artificial intelligence for natural product drug discovery. Nature reviews. Drug discovery (2023)
Franziska Fries, Andreas Martin Kany, Sari Rasheed, Anna Katharina Herta Hirsch, Daniel Krug, Jennifer Herrmann
Impact of Drug Administration Routes on the In Vivo Efficacy of the Natural Product Sorangicin a Using a Staphylococcus aureus Infection Model in Zebrafish Embryos. International journal of molecular sciences 24 (16) (2023)
Timm O Koller, Ullrich Scheid, Teresa Kösel, Jennifer Herrmann, Daniel Krug, Helena I M Boshoff, Bertrand Beckert, Joanna C Evans, Jan Schlemmer, Becky Sloan, Danielle M Weiner, Laura E Via, Atica Moosa, Thomas R Ioerger, Michael Graf, Boris Zinshteyn, Maha Abdelshahid, Fabian Nguyen, Stefan Arenz, Franziska Gille, Maik Siebke, Tim Seedorf, Oliver Plettenburg, Rachel Green, Anna-Luisa Warnke, Joachim Ullrich, Ralf Warrass, Clifton E Barry, Digby Francis Warner, Valerie Mizrahi, Andreas Kirschning, Daniel N Wilson, Daniel Krug
The Myxobacterial Antibiotic Myxovalargin: Biosynthesis, Structural Revision, Total Synthesis, and Molecular Characterization of Ribosomal Inhibition. Journal of the American Chemical Society 145 (2) (2023)
Mariam Rima, Niels Pfennigwerth, Martina Cremanns, Katarina Cirnski, Saoussen Oueslati, Sören G Gatermann, Nicola d'Amélio, Jennifer Herrmann, Daniel Krug, Thierry Naas
In Vitro Activity of Two Novel Antimicrobial Compounds on MDR-Resistant Clinical Isolates. Antibiotics (Basel, Switzerland) 12 (8) (2023)
Yunsheng Gao, Christine Walt, Chantal D Bader, Daniel Krug
Genome-Guided Discovery of the Myxobacterial Thiolactone-Containing Sorangibactins. ACS chemical biology (2023)
Timm O Koller, Ullrich Scheid, Teresa Kösel, Jennifer Herrmann, Daniel Krug, Helena I M Boshoff, Bertrand Beckert, Joanna C Evans, Jan Schlemmer, Becky Sloan, Danielle M Weiner, Laura E Via, Atica Moosa, Thomas R Ioerger, Michael Graf, Boris Zinshteyn, Maha Abdelshahid, Fabian Nguyen, Stefan Arenz, Franziska Gille, Maik Siebke, Tim Seedorf, Oliver Plettenburg, Rachel Green, Anna-Luisa Warnke, Joachim Ullrich, Ralf Warrass, Clifton E Barry, Digby Francis Warner, Valerie Mizrahi, Andreas Kirschning, Daniel N Wilson, Daniel Krug
The Myxobacterial Antibiotic Myxovalargin: Biosynthesis, Structural Revision, Total Synthesis, and Molecular Characterization of Ribosomal Inhibition. Journal of the American Chemical Society 145 (2) (2023)
Judith Boldt, Laima Lukoševičiūtė, Chengzhang Fu, Matthias Steglich, Boyke Bunk, Vera Junker, Aileen Gollasch, Birte Trunkwalter, Kathrin I Mohr, Michael Beckstette, Joachim Wink, Jörg Overmann, Daniel Krug, Ulrich Nübel
Bursts in biosynthetic gene cluster transcription are accompanied by surges of natural compound production in the myxobacterium Sorangium sp. Microbial biotechnology (2023)
Timm O Koller, Ullrich Scheid, Teresa Kösel, Jennifer Herrmann, Daniel Krug, Helena I M Boshoff, Bertrand Beckert, Joanna C Evans, Jan Schlemmer, Becky Sloan, Danielle M Weiner, Laura E Via, Atica Moosa, Thomas R Ioerger, Michael Graf, Boris Zinshteyn, Maha Abdelshahid, Fabian Nguyen, Stefan Arenz, Franziska Gille, Maik Siebke, Tim Seedorf, Oliver Plettenburg, Rachel Green, Anna-Luisa Warnke, Joachim Ullrich, Ralf Warrass, Clifton E Barry, Digby Francis Warner, Valerie Mizrahi, Andreas Kirschning, Daniel N Wilson, Daniel Krug
The Myxobacterial Antibiotic Myxovalargin: Biosynthesis, Structural Revision, Total Synthesis, and Molecular Characterization of Ribosomal Inhibition. Journal of the American Chemical Society 145 (2) (2023)
Carsten E Seyfert, Alison V Müller, Danica J Walsh, Joy Birkelbach, Andreas M Kany, Christoph Porten, Biao Yuan, Daniel Krug, Jennifer Herrmann, Thomas C Marlovits, Anna Katharina Herta Hirsch, Daniel Krug
New Genetically Engineered Derivatives of Antibacterial Darobactins Underpin Their Potential for Antibiotic Development. Journal of medicinal chemistry 66 (23) (2023)
Timm O Koller, Ullrich Scheid, Teresa Kösel, Jennifer Herrmann, Daniel Krug, Helena I M Boshoff, Bertrand Beckert, Joanna C Evans, Jan Schlemmer, Becky Sloan, Danielle M Weiner, Laura E Via, Atica Moosa, Thomas R Ioerger, Michael Graf, Boris Zinshteyn, Maha Abdelshahid, Fabian Nguyen, Stefan Arenz, Franziska Gille, Maik Siebke, Tim Seedorf, Oliver Plettenburg, Rachel Green, Anna-Luisa Warnke, Joachim Ullrich, Ralf Warrass, Clifton E Barry, Digby Francis Warner, Valerie Mizrahi, Andreas Kirschning, Daniel N Wilson, Daniel Krug
The Myxobacterial Antibiotic Myxovalargin: Biosynthesis, Structural Revision, Total Synthesis, and Molecular Characterization of Ribosomal Inhibition. Journal of the American Chemical Society 145 (2) (2023)
Walter Hofer, Emilia Oueis, Antoine Abou Fayad, Felix Deschner, Anastasia Andreas, Laìs Pessanha de Carvalho, Stephan Hüttel, Steffen Bernecker, Linda Pätzold, Bernd Morgenstern, Nestor Zaburannyi, Markus Bischoff, Marc Stadler, Jana Held, Jennifer Herrmann, Daniel Krug
Regio- and Stereoselective Epoxidation and Acidic Epoxide Opening of Antibacterial and Antiplasmodial Chlorotonils Yield Highly Potent Derivatives. Angewandte Chemie (International ed. in English) 61 (30) (2022)
Sara Forcisi, Franco Moritz, Christopher J Thompson, Basem Kanawati, Jenny Uhl, Carlos Afonso, Chantal D Bader, Aiko Barsch, Berin A Boughton, Rosalie K Chu, Justine Ferey, Francisco Fernandez Lima, Céline Guéguen, Dimitri Heintz, Mario Gomez-Hernandez, Kyoung-Soon Jang, Nikolas Kessler, Vaughn Mangal, Daniel Krug, Ryo Nakabayashi, Edith Nicol, Simone Nicolardi, Magnus Palmblad, Ljiljana Paša-Tolić, Jacob Porter, Isabelle Schmitz-Afonso, Jong Bok Seo, Eduardo Sommella, Yuri E M van der Burgt, Claire Villette, Matthias Witt, Ashley Wittrig, Jeremy J Wolff, Michael L Easterling, Frank H Laukien, Philippe Schmitt-Kopplin
Large-Scale Interlaboratory DI-FT-ICR MS Comparability Study Employing Various Systems. Journal of the American Society for Mass Spectrometry 33 (12) (2022)
Julian D Hegemann, Joy Birkelbach, Sebastian Walesch, Daniel Krug
Current developments in antibiotic discovery: Global microbial diversity as a source for evolutionary optimized anti-bacterials: Global microbial diversity as a source for evolutionary optimized anti-bacterials. EMBO reports 24 (1) (2022)
Susanne H Kirsch, F P Jake Haeckl, Daniel Krug
Beyond the approved: target sites and inhibitors of bacterial RNA polymerase from bacteria and fungi. Natural product reports 39 (6) (2022)
Kristine A Keon, Samir Benlekbir, Susanne H Kirsch, Daniel Krug, John L Rubinstein
Cryo-EM of the Yeast V O Complex Reveals Distinct Binding Sites for Macrolide V-ATPase Inhibitors. ACS chemical biology 17 (3) (2022)
Anna K Krome, Tim Becker, Stefan Kehraus, Andrea Schiefer, Michael Gütschow, Lillibeth Chaverra-Muñoz, Stephan Hüttel, Rolf Jansen, Marc Stadler, Alexandra Ehrens, Domen Pogorevc, Daniel Krug, Marc P Hübner, Thomas Hesterkamp, Kenneth M Pfarr, Achim Hoerauf, Karl G Wagner, Gabriele M König
Corallopyronin A: antimicrobial discovery to preclinical development. Natural product reports 39 (9) (2022)
Athina Gavrilidou, Satria A Kautsar, Nestor Zaburannyi, Daniel Krug, Daniel Krug, Marnix H Medema, Nadine Ziemert
Compendium of specialized metabolite biosynthetic diversity encoded in bacterial genomes. Nature microbiology 7 (5) (2022)
Di Zhu, Sandra Johannsen, Tiziana Masini, Céline Simonin, Jörg Haupenthal, Boris Illarionov, Anastasia Andreas, Mahendra Awale, Robin M Gierse, Tridia van der Laan, Ramon van der Vlag, Rita Nasti, Mael Poizat, Eric Buhler, Norbert Reiling, Daniel Krug, Markus Fischer, Jean-Louis Reymond, Anna Katharina Herta Hirsch
Discovery of novel drug-like antitubercular hits targeting the MEP pathway enzyme DXPS by strategic application of ligand-based virtual screening. Chemical science 13 (36) (2022)
Cansu Kaya, Isabell Walter, Alaa Alhayek, Roya Shafiei, Gwenaëlle Jézéquel, Anastasia Andreas, Jelena Konstantinović, Esther Schönauer, Asfandyar Sikandar, Jörg Haupenthal, Daniel Krug, Hans Brandstetter, Rolf Wolfgang Hartmann, Anna Katharina Herta Hirsch
Structure-Based Design of α-Substituted Mercaptoacetamides as Inhibitors of the Virulence Factor LasB from Pseudomonas aeruginosa . ACS infectious diseases 8 (5) (2022)
Cédric Couturier, Sebastian Groß, Alexander von Tesmar, Judith Hoffmann, Selina Deckarm, Anouchka Fievet, Nelly Dubarry, Thomas Taillier, Christoph Pöverlein, Heike Stump, Michael Kurz, Luigi Toti, Sabine Haag Richter, Dietmar Schummer, Philippe Sizun, Michael Hoffmann, Ram Prasad Awal, Nestor Zaburannyi, Kirsten Harmrolfs, Joachim Wink, Emilie Lessoud, Thierry Vermat, Veronique Cazals, Sandra Silve, Armin Bauer, Michael Mourez, Laurent Fraisse, Corinne Leroi-Geissler, Astrid Rey, Stéphanie Versluys, Eric Bacqué, Daniel Krug, Stephane Renard
Structure Elucidation, Total Synthesis, Antibacterial In Vivo Efficacy and Biosynthesis Proposal of Myxobacterial Corramycin. Angewandte Chemie (International ed. in English) (2022)
Sebastian Walesch, Joy Birkelbach, Gwenaëlle Jézéquel, F P Jake Haeckl, Julian D Hegemann, Thomas Hesterkamp, Anna Katharina Herta Hirsch, Peter Hammann, Daniel Krug
Fighting antibiotic resistance-strategies and (pre)clinical developments to find new antibacterials. EMBO reports (2022)
Michael Kohr, Christine Walt, Jan Dastbaz, Daniel Krug, Uli Kazmaier
Total synthesis of Myxoprincomide, a secondary metabolite from Myxococcus xanthus . Organic & biomolecular chemistry (2022)
Philipp Lapuhs, Eilien Heinrich, Ronald Garcia, Adriely Goes, Nicolas Frank, Lukas Bollenbach, Veronika Stibane, Thomas Kuhn, Marcus Koch, Alexandra K Kiemer, Daniel Krug, Kathrin Fuhrmann, Molly M Stevens
The inherent antibiotic activity of myxobacteria-derived autofluorescent outer membrane vesicles is switched on and off by light stimulation. Nanoscale 14 (47) (2022)
Carsten E Seyfert, Christoph Porten, Biao Yuan, Selina Deckarm, Fabian Panter, Chantal D Bader, Janetta Coetzee, Felix Deschner, Kamaleddin H M E Tehrani, Paul G Higgins, Harald Seifert, Thomas C Marlovits, Jennifer Herrmann, Daniel Krug
Darobactins Exhibiting Superior Antibiotic Activity by Cryo-EM Structure Guided Biosynthetic Engineering. Angewandte Chemie (International ed. in English) (2022)
Jaryd R Sullivan, Jacqueline Yao, Christophe Courtine, Andréanne Lupien, Jennifer Herrmann, Daniel Krug, Marcel A Behr
Natural Products Lysobactin and Sorangicin A Show In Vitro Activity against Mycobacterium abscessus Complex. Microbiology spectrum (2022)
Yi-Ming Shi, Merle Hirschmann, Yan-Ni Shi, Shabbir Ahmed, Desalegne Abebew, Nicholas J Tobias, Peter Grün, Jan J Crames, Laura Pöschel, Wolfgang Kuttenlochner, Christian Richter, Jennifer Herrmann, Daniel Krug, Aunchalee Thanwisai, Sacha J Pidot, Timothy P Stinear, Michael Groll, Yong-Gyun Kim, Helge B Bode
Global analysis of biosynthetic gene clusters reveals conserved and unique natural products in entomopathogenic nematode-symbiotic bacteria. Nature chemistry 14 (6) (2022)
Julian D Hegemann, Joy Birkelbach, Sebastian Walesch, Daniel Krug
Current developments in antibiotic discovery: Global microbial diversity as a source for evolutionary optimized anti-bacterials: Global microbial diversity as a source for evolutionary optimized anti-bacterials. EMBO reports 24 (1) (2022)
Sebastian Walesch, Joy Birkelbach, Gwenaëlle Jézéquel, F P Jake Haeckl, Julian D Hegemann, Thomas Hesterkamp, Anna Katharina Herta Hirsch, Peter Hammann, Daniel Krug
Fighting antibiotic resistance-strategies and (pre)clinical developments to find new antibacterials. EMBO reports 24 (1) (2022)
Fabian Panter, Alexander Popoff, Ronald Garcia, Daniel Krug, Daniel Krug
Myxobacteria of the Cystobacterineae Suborder Are Producers of New Vitamin K 2 Derived Myxoquinones. Microorganisms 10 (3) (2022)
Dorothy A Okoth, Joachim J Hug, Ronald Garcia, Daniel Krug
Three New Stigmatellin Derivatives Reveal Biosynthetic Insights of Its Side Chain Decoration. Molecules (Basel, Switzerland) 27 (14) (2022)
Asfandyar Sikandar, Maria Lopatniuk, Andriy Luzhetskyy, Daniel Krug, Jesko Koehnke
Total In Vitro Biosynthesis of the Thioamitide Thioholgamide and Investigation of the Pathway. Journal of the American Chemical Society 144 (11) (2022)
Chantal D Bader, Fabian Panter, Ronald Garcia, Egor P Tchesnokov, Sibylle Haid, Christine Walt, Cathrin Spröer, Alexander F Kiefer, Matthias Götte, Joerg Overmann, Thomas Pietschmann, Daniel Krug
Sandacrabins - Structurally Unique Antiviral RNA Polymerase Inhibitors from a Rare Myxobacterium. Chemistry (Weinheim an der Bergstrasse, Germany) 28 (10) (2022)
Julian D Hegemann, Joy Birkelbach, Sebastian Walesch, Daniel Krug
Current developments in antibiotic discovery: Global microbial diversity as a source for evolutionary optimized anti-bacterials: Global microbial diversity as a source for evolutionary optimized anti-bacterials. EMBO reports (2022)
Julian D Hegemann, Joy Birkelbach, Sebastian Walesch, Daniel Krug
Current developments in antibiotic discovery: Global microbial diversity as a source for evolutionary optimized anti-bacterials: Global microbial diversity as a source for evolutionary optimized anti-bacterials. EMBO reports 24 (1) (2022)
Sebastian Walesch, Joy Birkelbach, Gwenaëlle Jézéquel, F P Jake Haeckl, Julian D Hegemann, Thomas Hesterkamp, Anna Katharina Herta Hirsch, Peter Hammann, Daniel Krug
Fighting antibiotic resistance-strategies and (pre)clinical developments to find new antibacterials. EMBO reports 24 (1) (2022)
Cansu Kaya, Jelena Konstantinović, Andreas M Kany, Anastasia Andreas, Jan S Kramer, Steffen Brunst, Lilia Weizel, Marco J Rotter, Denia Frank, Samir Yahiaoui, Daniel Krug, Rolf Wolfgang Hartmann, Jörg Haupenthal, Ewgenij Proschak, Thomas A Wichelhaus, Anna Katharina Herta Hirsch
N -Aryl Mercaptopropionamides as Broad-Spectrum Inhibitors of Metallo-β-Lactamases. Journal of medicinal chemistry 65 (5) (2022)
Dorothy A Okoth, Joachim J Hug, Ronald Garcia, Daniel Krug
Discovery, Biosynthesis and Biological Activity of a Succinylated Myxochelin from the Myxobacterial Strain MSr12020. Microorganisms 10 (10) (2022)
Sebastian Walesch, Joy Birkelbach, Gwenaëlle Jézéquel, F P Jake Haeckl, Julian D Hegemann, Thomas Hesterkamp, Anna Katharina Herta Hirsch, Peter Hammann, Daniel Krug
Fighting antibiotic resistance-strategies and (pre)clinical developments to find new antibacterials. EMBO reports 24 (1) (2022)
Julian D Hegemann, Joy Birkelbach, Sebastian Walesch, Daniel Krug
Current developments in antibiotic discovery: Global microbial diversity as a source for evolutionary optimized anti-bacterials: Global microbial diversity as a source for evolutionary optimized anti-bacterials. EMBO reports 24 (1) (2022)
Hu Zeng, Joy Birkelbach, Judith Hoffmann, Alexander Popoff, Carsten Volz, Daniel Krug
Expanding the Ajudazol Cytotoxin Scaffold: Insights from Genome Mining, Biosynthetic Investigations, and Novel Derivatives. Journal of natural products 85 (11) (2022)
Sebastian Walesch, Joy Birkelbach, Gwenaëlle Jézéquel, F P Jake Haeckl, Julian D Hegemann, Thomas Hesterkamp, Anna Katharina Herta Hirsch, Peter Hammann, Daniel Krug
Fighting antibiotic resistance-strategies and (pre)clinical developments to find new antibacterials. EMBO reports 24 (1) (2022)
Patrick A Haack, Kirsten Harmrolfs, Chantal D Bader, Ronald Garcia, Antonia P Gunesch, Sibylle Haid, Alexander Popoff, Alexander Voltz, Heeyoung Kim, Ralf Bartenschlager, Thomas Pietschmann, Daniel Krug
Thiamyxins: Structure and Biosynthesis of Myxobacterial RNA-Virus Inhibitors. Angewandte Chemie (International ed. in English) (2022)
Marcus Miethke, Marco Pieroni, Tilmann Weber, Mark Brönstrup, Peter Hammann, Ludovic Halby, Paola B Arimondo, Philippe Glaser, Bertrand Aigle, Helge B Bode, Rui Moreira, Yanyan Li, Andriy Luzhetskyy, Marnix H Medema, Jean-Luc Pernodet, Marc Stadler, José Rubén Tormo, Olga Genilloud, Andrew W Truman, Kira J Weissman, Eriko Takano, Stefano Sabatini, Evi Stegmann, Heike Brötz-Oesterhelt, Wolfgang Wohlleben, Myriam Seemann, Martin Empting, Anna K H Hirsch, Brigitta Loretz, Claus-Michael Lehr, Alexander Titz, Jennifer Herrmann, Timo Jaeger, Silke Alt, Thomas Hesterkamp, Mathias Winterhalter, Andrea Schiefer, Kenneth M Pfarr, Achim Hoerauf, Heather Graz, Michael Graz, Mika Lindvall, Savithri Ramurthy, Anders Karlén, Maarten van Dongen, Hrvoje Petkovic, Andreas Keller, Frédéric Peyrane, Stefano Donadio, Laurent Fraisse, Laura J V Piddock, Ian H Gilbert, Heinz E Moser, Daniel Krug
Towards the sustainable discovery and development of new antibiotics. Nature reviews. Chemistry 5 (10) (2021)
Robert Richter, Mohamed A M Kamal, Marcus Koch, Bart-Jan Niebuur, Anna-Lena Huber, Adriely Goes, Carsten Volz, Julia Vergalli, Tobias Kraus, Daniel Krug, Nicole Schneider-Daum, Molly M Stevens, Jean Marie Pagès, Claus-Michael Lehr
An Outer Membrane Vesicle-Based Permeation Assay (OMPA) for Assessing Bacterial Bioavailability. Advanced healthcare materials (2021)
Chantal D Bader, Patrick A Haack, Fabian Panter, Daniel Krug, Daniel Krug
Expanding the Scope of Detectable Microbial Natural Products by Complementary Analytical Methods and Cultivation Systems. Journal of natural products 84 (2) (2021)
Nanaji Arisetti, Hazel L S Fuchs, Janetta Coetzee, Manuel Orozco, Dominik Ruppelt, Armin Bauer, Dominik Heimann, Eric Kuhnert, Satya P Bhamidimarri, Jayesh A Bafna, Bettina Hinkelmann, Konstantin Eckel, Stephan A Sieber, Peter P Mueller, Jennifer Herrmann, Daniel Krug, Mathias Winterhalter, Claudia Steinem, Mark Brönstrup
Total synthesis and mechanism of action of the antibiotic armeniaspirol A. Chemical science 12 (48) (2021)
Jiaqi Liu, Haibo Zhou, Zhiyu Yang, Xue Wang, Hanna Chen, Lin Zhong, Wentao Zheng, Weijing Niu, Sen Wang, Xiangmei Ren, Guannan Zhong, Yan Wang, Xiaoming Ding, Daniel Krug, Youming Zhang, Xiaoying Bian
Rational construction of genome-reduced Burkholderiales chassis facilitates efficient heterologous production of natural products from proteobacteria. Nature communications 12 (1) (2021)
Marcus Miethke, Marco Pieroni, Tilmann Weber, Mark Brönstrup, Peter Hammann, Ludovic Halby, Paola B Arimondo, Philippe Glaser, Bertrand Aigle, Helge B Bode, Rui Moreira, Yanyan Li, Andriy Luzhetskyy, Marnix H Medema, Jean-Luc Pernodet, Marc Stadler, José Rubén Tormo, Olga Genilloud, Andrew W Truman, Kira J Weissman, Eriko Takano, Stefano Sabatini, Evi Stegmann, Heike Brötz-Oesterhelt, Wolfgang Wohlleben, Myriam Seemann, Martin Empting, Anna K H Hirsch, Brigitta Loretz, Claus-Michael Lehr, Alexander Titz, Jennifer Herrmann, Timo Jaeger, Silke Alt, Thomas Hesterkamp, Mathias Winterhalter, Andrea Schiefer, Kenneth M Pfarr, Achim Hoerauf, Heather Graz, Michael Graz, Mika Lindvall, Savithri Ramurthy, Anders Karlén, Maarten van Dongen, Hrvoje Petkovic, Andreas Keller, Frédéric Peyrane, Stefano Donadio, Laurent Fraisse, Laura J V Piddock, Ian H Gilbert, Heinz E Moser, Daniel Krug
Towards the sustainable discovery and development of new antibiotics. Nature reviews. Chemistry 5 (10) (2021)
Katrin Voos, Esther Schönauer, Alaa Alhayek, Jörg Haupenthal, Anastasia Andreas, Daniel Krug, Rolf Wolfgang Hartmann, Katharina Häussermann, Anna Katharina Herta Hirsch, Christian Ducho
Phosphonate as a Stable Zinc-Binding Group for "Pathoblocker" Inhibitors of Clostridial Collagenase H (ColH). ChemMedChem 16 (8) (2021)
Sebastian Groß, Fabian Panter, Domen Pogorevc, Carsten E Seyfert, Selina Deckarm, Chantal D Bader, Jennifer Herrmann, Daniel Krug
Improved broad-spectrum antibiotics against Gram-negative pathogens via darobactin biosynthetic pathway engineering. Chemical science 12 (35) (2021)
Dorothy A Okoth, Joachim J Hug, Attila Mándi, Tibor Kurtán, Ronald Garcia, Daniel Krug
Structure and biosynthesis of sorangipyranone - a new γ-dihydropyrone from the myxobacterial strain MSr12020. Journal of industrial microbiology & biotechnology 48 (3-4) (2021)
Domen Pogorevc, Daniel Krug
Biotechnological production optimization of argyrins - a potent immunomodulatory natural product class. Microbial biotechnology (2021)
Antonia Grauel, Jan Kägi, Tim Rasmussen, Iryna Makarchuk, Sabrina Oppermann, Aurélien F A Moumbock, Daniel Wohlwend, Daniel Krug, Frederic Melin, Stefan Günther, Petra Hellwig, Bettina Boettcher, Thorsten Friedrich
Structure of Escherichia coli cytochrome bd-II type oxidase with bound aurachin D. Nature communications 12 (1) (2021)
Marcus Miethke, Marco Pieroni, Tilmann Weber, Mark Brönstrup, Peter Hammann, Ludovic Halby, Paola B Arimondo, Philippe Glaser, Bertrand Aigle, Helge B Bode, Rui Moreira, Yanyan Li, Andriy Luzhetskyy, Marnix H Medema, Jean-Luc Pernodet, Marc Stadler, José Rubén Tormo, Olga Genilloud, Andrew W Truman, Kira J Weissman, Eriko Takano, Stefano Sabatini, Evi Stegmann, Heike Brötz-Oesterhelt, Wolfgang Wohlleben, Myriam Seemann, Martin Empting, Anna K H Hirsch, Brigitta Loretz, Claus-Michael Lehr, Alexander Titz, Jennifer Herrmann, Timo Jaeger, Silke Alt, Thomas Hesterkamp, Mathias Winterhalter, Andrea Schiefer, Kenneth M Pfarr, Achim Hoerauf, Heather Graz, Michael Graz, Mika Lindvall, Savithri Ramurthy, Anders Karlén, Maarten van Dongen, Hrvoje Petkovic, Andreas Keller, Frédéric Peyrane, Stefano Donadio, Laurent Fraisse, Laura J V Piddock, Ian H Gilbert, Heinz E Moser, Daniel Krug
Towards the sustainable discovery and development of new antibiotics. Nature reviews. Chemistry (2021)

Daniel Krug.css-eqlu8i{font-size:small;padding-left:4px;} (Rolf Müller)

Publication Activity (10 Years)

Top Topics

Top Venues

Daniel Krug (Rolf Müller)